The Utility of Mass Spectrometry in Defining Minimal Residual Disease in Treated Multiple Myeloma Patients

被引：0
|
作者：
Campbell, Lauren [1 ]
Lau, I-Jun [2 ]
Ramasamy, Karthik [3 ]
Sadler, Ross [1 ]
机构：
[1] Oxford Univ Hosp NHS Fdn Trust, Oxford, England
[2] Botnar Inst, Oxford, England
[3] Radcliffe Dept Med, Oxford, England
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-184
引用
收藏
页码：S144 / S145
页数：2
相关论文
共 50 条
  • [41] Drug resistance and minimal residual disease in multiple myeloma
    Gozzetti, Alessandro
    Ciofini, Sara
    Sicuranza, Anna
    Pacelli, Paola
    Raspadori, Donatella
    Cencini, Emanuele
    Tocci, Dania
    Bocchia, Monica
    CANCER DRUG RESISTANCE, 2022, 5 (01) : 171 - 183
  • [42] Recommendations for quantitation of minimal residual disease in multiple myeloma
    Rasmussen, T
    Johnsen, HE
    BONE MARROW TRANSPLANTATION, 2002, 29 : S128 - S128
  • [43] Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma
    Kim, Hyun-Young
    Yoo, In Young
    Lim, Dae Jin
    Kim, Hee-Jin
    Kim, Sun-Hee
    Yoon, Sang Eun
    Kim, Seok Jin
    Cho, Duck
    Kim, Kihyun
    ANNALS OF LABORATORY MEDICINE, 2022, 42 (05) : 558 - +
  • [44] Targeting minimal residual disease in myeloma patients
    Kroeger, N.
    ONKOLOGIE, 2010, 33 : 10 - 11
  • [45] Molecular Monitoring of Minimal Residual Disease in the Peripheral Blood of Patients with Multiple Myeloma
    Korthals, Mark
    Sehnke, Nina
    Kronenwett, Ralf
    Schroeder, Thomas
    Strapatsas, Tobias
    Kobbe, Guido
    Haas, Rainer
    Fenk, Roland
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (07) : 1109 - 1115
  • [46] Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients
    Paiva, Bruno
    Cedena, Maria-Teresa
    Puig, Noemi
    Arana, Paula
    Vidriales, Maria-Belen
    Cordon, Lourdes
    Flores-Montero, Juan
    Gutierrez, Norma C.
    Martin-Ramos, Maria-Luisa
    Martinez-Lopez, Joaquin
    Ocio, Enrique M.
    Hernandez, Miguel T.
    Teruel, Ana-Isabel
    Rosinol, Laura
    Echeveste, Maria-Asuncion
    Martinez, Rafael
    Gironella, Mercedes
    Oriol, Albert
    Cabrera, Carmen
    Martin, Jesus
    Bargay, Joan
    Encinas, Cristina
    Gonzalez, Yolanda
    Van Dongen, Jacques J. M.
    Orfao, Alberto
    Blade, Joan
    Mateos, Maria-Victoria
    Jose Lahuerta, Juan
    San Miguel, Jesus F.
    BLOOD, 2016, 127 (25) : 3165 - 3174
  • [47] Functional and psychological impact of minimal residual disease assessment on patients with multiple myeloma
    Correia, Nuno
    Dowling, Emma
    Popat, Rakesh
    Rabin, Neil
    Kyriakou, Chara
    Sive, Jonathan
    Yong, Kwee
    Wechalekar, Ashutosh
    BRITISH JOURNAL OF HAEMATOLOGY, 2023,
  • [48] Defining the undetectable: The current landscape of minimal residual disease assessment in multiple myeloma and goals for future clarity
    Diamond, Benjamin T.
    Rustad, Even
    Maclachlan, Kylee
    Thoren, Katie
    Ho, Caleb
    Roshal, Mikhail
    Ulaner, Gary A.
    Landgren, C. Ola
    BLOOD REVIEWS, 2021, 46
  • [49] Clonotypic Mass Spectrometry with Easym Assay for Detection of Measurable Residual Disease in Multiple Myeloma
    Slade, Michael J.
    Khalid, Abir
    Fiala, Mark A.
    Liyasova, Mariya
    Zaydman, Mark A.
    McDonald, Zac
    Fortier, Julie M.
    Kelley, Sarah
    Crees, Zachary D.
    Schroeder, Mark A.
    Stockerl-Goldstein, Keith E.
    Yang, Liqiang
    Vij, Ravi
    BLOOD, 2022, 140 : 4376 - 4377
  • [50] B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients
    Mendonca de Pontes, Roberia
    Flores-Montero, Juan
    Sanoja-Flores, Luzalba
    Puig, Noemi
    Pessoa de Magalhaes, Roberto J.
    Corral-Mateos, Alba
    Salgado, Anna Beatriz
    Garcia-Sanchez, Omar
    Perez-Moran, Jose
    Mateos, Maria-Victoria
    Burgos, Leire
    Paiva, Bruno
    te Marvelde, Jeroen
    van der Velden, Vincent H. J.
    Aguilar, Carlos
    Barez, Abelardo
    Garcia-Mateo, Aranzazu
    Labrador, Jorge
    Leoz, Pilar
    Aguilera-Sanz, Carmen
    Durie, Brian
    van Dongen, Jacques J. M.
    Maiolino, Angelo
    Sobral da Costa, Elaine
    Orfao, Alberto
    CANCERS, 2021, 13 (07)
12345